文献速递呼吸衰竭与机械通气心脑血管急症重症综合管理与镇静镇痛

心力衰竭与通气支持模式对肥胖低通气综合征患者或高危人群住院发病率与死亡率的影响:基于全国住院患者样本的发现

The Influence of Heart Failure and Ventilatory Support Mode on Hospital Morbidity and Mortality in Patients With or at Risk of Obesity Hypoventilation Syndrome: Findings From the National Inpatient Sample.
PubMed 文献 · Chest · 2026-01-07
一句话结论合并心衰的肥胖低通气综合征患者住院期间无创通气、有创通气或两者联合使用率更高,但未改善任何结局;联合通气者所有结局更差。

该研究利用2016—2020年全国住院患者样本,纳入72,385例因肥胖低通气综合征住院的患者,其中58.8%合并心衰诊断、26.3%以心衰为主要出院诊断。合并心衰者年龄更大(平均60岁 vs 54岁)、白人比例更高(56.9% vs 43.1%)、住院时间更长(中位6天 vs 5天),且独立与需要无创通气(OR 1.35)、有创通气(OR 1.34)及两者联合(OR 1.67)相关。合并心衰者出院回家可能性更低(OR 0.83;P < .001)、院内死亡更多(OR 1.27)、不良心血管结局更频繁(OR 1.20)。心衰患者无创通气、有创通气或两者联合使用率更高(36% vs 30%;P < .001),但未改善任何上述结局;联合使用无创与有创通气者较单用任一模式者院内死亡率更高(OR 14.8 vs 13.1 vs 1.5)、急性肾损伤更多(OR 3.9 vs 3.0 vs 1.3)、主要不良心脏事件更多(OR 2.9 vs 2.4 vs 1.1)。

要点

  • 因肥胖低通气综合征住院患者中58.8%合并心衰诊断,26.3%以心衰为主要出院诊断。
  • 合并心衰独立与需要无创通气(OR 1.35)、有创通气(OR 1.34)及两者联合(OR 1.67)相关。
  • 合并心衰者院内死亡更多(OR 1.27)、不良心血管结局更频繁(OR 1.20)、出院回家可能性更低(OR 0.83;P < .001)。
  • 心衰患者无创通气、有创通气或两者联合使用率更高(36% vs 30%;P < .001),但未改善任何结局。
  • 联合使用无创与有创通气者较单用任一模式者院内死亡率更高(OR 14.8 vs 13.1 vs 1.5)、急性肾损伤更多(OR 3.9 vs 3.0 vs 1.3)、主要不良心脏事件更多(OR 2.9 vs 2.4 vs 1.1)。

适用人群与场景

  • 2016—2020年全国住院患者样本中因肥胖低通气综合征住院或存在其风险的患者,共72,385例。
  • 合并心衰诊断者占58.8%,以心衰为主要出院诊断者占26.3%。

研究设计与关键结果

  • 研究类型:基于全国住院患者样本(2016—2020)的分析,纳入72,385例因肥胖低通气综合征住院或存在其风险的患者。
  • 合并心衰者年龄更大(平均60岁 vs 54岁)、白人比例更高(56.9% vs 43.1%)、住院时间更长(中位6天 vs 5天)。
  • 合并心衰独立与需要无创通气(OR 1.35)、有创通气(OR 1.34)及无创联合有创通气(OR 1.67)相关。
  • 合并心衰者出院回家可能性更低(OR 0.83;P < .001)、院内死亡更多(OR 1.27)、不良心血管结局更频繁(OR 1.20)。
  • 心衰患者无创通气、有创通气或两者联合使用率更高(36% vs 30%;P < .001),但未改善任何上述结局。
  • 联合使用无创与有创通气者较单用有创通气或单用无创通气者院内死亡率更高(OR 14.8 vs 13.1 vs 1.5)、急性肾损伤更多(OR 3.9 vs 3.0 vs 1.3)、主要不良心脏事件更多(OR 2.9 vs 2.4 vs 1.1)。

证据类型、等级与局限

  • 证据类型:基于全国住院患者样本(2016—2020)的回顾性分析,校正临床相关混杂因素。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 合并心衰的肥胖低通气综合征住院患者无创通气、有创通气或两者联合使用率更高,但未改善任何结局。
  • 联合使用无创与有创通气者所有结局均更差。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Heart failure (HF) is common in obesity hypoventilation syndrome (OHS). We explored the impact of HF on in-hospital outcomes of patients with or at risk of OHS who were treated with mechanical ventilation (MV), noninvasive ventilation (NIV), or both.

RESEARCH QUESTION: What is the outcome of patients with OHS who experience HF?

STUDY DESIGN AND METHODS: The National Inpatient Sample (2016-2020) was queried to extract data on patients with or at risk of OHS. The association of adverse outcomes with HF in patients with OHS was explored by analysis adjusted for clinically relevant confounders.

RESULTS: Among 72,385 patients hospitalized for OHS, 58.8% of patients received an underlying diagnosis of HF and 26.3% of patients were discharged with a primary diagnosis of HF. Patients with OHS and HF were older (mean age, 60 years vs 54 years), frequently White (56.9% vs 43.1%), had a longer length of stay (median, 6 days vs 5 days), and independently were associated with a need for NIV (OR, 1.35), MV (OR, 1.34) and NIV plus MV (OR, 1.67). Patients with HF showed a lower likelihood of discharge to home (OR, 0.83; P < .001], more in-hospital deaths (OR, 1.27), and more frequent adverse cardiovascular outcomes (OR, 1.20). Use of NIV, MV, or both was higher in patients with HF (36% vs 30%; P < .001), but did not result in improvement in any of the noted outcomes. When NIV was used in conjunction with MV, higher inpatient mortality (OR, 14.8 vs 13.1 vs 1.5), more acute kidney injury (OR, 3.9 vs 3.0 vs 1.3), and more major adverse cardiac events (OR, 2.9 vs 2.4 vs 1.1) were reported when compared with use of either MV or NIV alone.

INTERPRETATION: Comorbid HF exists in 59% of hospitalized patients with or at risk of OHS. Use of NIV, MV, or both was higher in patients with HF, but did not result in improvement in any outcomes. All outcomes were worse in patients who received both NIV and MV.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Kaw R, Shekhar S, Mehra R, et al. The Influence of Heart Failure and Ventilatory Support Mode on Hospital Morbidity and Mortality in Patients With or at Risk of Obesity Hypoventilation Syndrome: Findings From the National Inpatient Sample. Chest. 2026. PMID: 41513123. doi:10.1016/j.chest.2025.11.039

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。